SeQuent Please Neo (BBraun Medical) is a balloon catheter for percutaneous transluminal coronary angioplasty. The balloon is coated with the antimitotic drug paclitaxel, with the aim of reducing restenosis. NICE issued medical technology guidance [MTG1] on this technology in 2010 and are now updating the guidance following a guidance review decision in early 2017.
 
Status In progress
Process MT
ID number 302

Project Team

Project lead Kimberley Carter

Email enquiries

Stakeholders

External assessment group Newcastle & York Consortium
Manufacturers B.Braun Vascular Systems
Others Bridgewater Community Health Trust
  Department of Health (DH)
  Healthcare Improvement Scotland (HIS)
  Johnson & Johnson Medical Ltd
  National Institute for Health Research Horizon Scanning Centre (NIHR)
  Medicines and Healthcare Products Regulatory Agency (MHRA)
  NHS England (NHSE)
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  BAPRAS
  British Association for Nursing in Cardiovascular Care
  British Cardiovascular Society
  Devices for Dignity
  Medical Technology Group
  The British In Vitro Diagnostics Association (BIVDA)

Timeline

Key events during the development of the guidance:

Date Update
20 October 2017 The guidance update schedule for this technology is currently being updated. New dates will be added to this page shortly.
30 August 2017 Scope published
10 August 2017 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance